DK0489423T3 - Galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelsen af disse forbindelser som lægemidler - Google Patents

Galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelsen af disse forbindelser som lægemidler

Info

Publication number: DK0489423T3
Authority: DK; Denmark
Prior art keywords: bile acid; acid derivatives; compounds; drugs; processes
Prior art date: 1990-12-06

Application number

DK91120841.1T

Other languages

English (en)

Inventor

Guenther Dr. Wess G

Werner Dr Kramer

Stefan Dr. Mueller

Horst Dr Neubauer

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-06

Filing date

1991-12-04

Publication date

1997-04-14

1991-12-04 Application filed by Hoechst Ag filed Critical Hoechst Ag

1997-04-14 Application granted granted Critical

1997-04-14 Publication of DK0489423T3 publication Critical patent/DK0489423T3/da

Links

HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical class C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 title abstract 4
150000001875 compounds Chemical class 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
239000003613 bile acid Substances 0.000 abstract 3
238000010521 absorption reaction Methods 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
150000007513 acids Chemical class 0.000 abstract 1
125000003158 alcohol group Chemical group 0.000 abstract 1
150000001408 amides Chemical class 0.000 abstract 1
230000002860 competitive effect Effects 0.000 abstract 1
230000001419 dependent effect Effects 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
150000003839 salts Chemical group 0.000 abstract 1
210000000813 small intestine Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
- C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Toxicology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Diaphragms For Electromechanical Transducers (AREA)
Motorcycle And Bicycle Frame (AREA)
Train Traffic Observation, Control, And Security (AREA)

DK91120841.1T 1990-12-06 1991-12-04 Galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelsen af disse forbindelser som lægemidler DK0489423T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4038833		1990-12-06

Publications (1)

Publication Number	Publication Date
DK0489423T3 true DK0489423T3 (da)	1997-04-14

Family

ID=6419672

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91120841.1T DK0489423T3 (da)	1990-12-06	1991-12-04	Galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelsen af disse forbindelser som lægemidler

Country Status (23)

Country	Link
US (1)	US5250524A (da)
EP (1)	EP0489423B1 (da)
JP (1)	JP3237882B2 (da)
KR (1)	KR100221690B1 (da)
AT (1)	ATE144988T1 (da)
AU (1)	AU649089B2 (da)
CA (1)	CA2057099C (da)
CZ (1)	CZ281075B6 (da)
DE (1)	DE59108326D1 (da)
DK (1)	DK0489423T3 (da)
ES (1)	ES2096614T3 (da)
FI (1)	FI106800B (da)
GR (1)	GR3021572T3 (da)
HR (1)	HRP940751B1 (da)
HU (2)	HU213402B (da)
IE (1)	IE914235A1 (da)
IL (1)	IL100240A (da)
NO (1)	NO304187B1 (da)
NZ (1)	NZ240846A (da)
PT (1)	PT99713B (da)
SI (1)	SI9111899B (da)
YU (1)	YU48636B (da)
ZA (1)	ZA919605B (da)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5795870A (en) *	1991-12-13	1998-08-18	Trustees Of Princeton University	Compositions and methods for cell transformation
NZ245504A (en) *	1991-12-20	1995-08-28	Hoechst Ag	Bile acid derivatives containing an ethylenically unsaturated grouping
FI108451B (fi) *	1991-12-20	2002-01-31	Hoechst Ag	Menetelmõ polymeeristen ja oligomeeristen sappihappojohdannaisten valmistamiseksi
IT1258788B (it) *	1992-01-17	1996-02-29	Giuliani Spa	Derivati solforati di acidi biliari
DK0573848T3 (da) *	1992-06-12	1998-08-10	Hoechst Ag	Galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler
EP0614908B1 (de) *	1993-03-09	1997-05-07	Hoechst Aktiengesellschaft	Verfahren zur Herstellung von 3beta-Aminocholansäurederivaten
CA2157594A1 (en) *	1993-03-10	1994-09-15	Leah L. Frye	Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants
EP0624593A3 (de) *	1993-05-08	1995-06-07	Hoechst Ag	Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel.
TW289757B (da) *	1993-05-08	1996-11-01	Hoechst Ag
TW289021B (da) *	1993-05-08	1996-10-21	Hoechst Ag
TW289020B (da) *	1993-05-08	1996-10-21	Hoechst Sktiengesellschaft
US5624963A (en) *	1993-06-02	1997-04-29	Geltex Pharmaceuticals, Inc.	Process for removing bile salts from a patient and compositions therefor
US5585470A (en) *	1994-06-23	1996-12-17	Transcell Technologies, Inc.	Process for the manufacture of 3-amino-substituted glycosylated bile acids
US5840740A (en) *	1995-06-07	1998-11-24	Magainin Pharmaceuticals Inc.	Aminosterol compounds and a method of treating infection using the aminosterol compounds
US5856535A (en) *	1994-08-18	1999-01-05	Magainin Pharmaceuticals, Inc.	Aminosterol ester compounds
DE4432708A1 (de) *	1994-09-14	1996-03-21	Hoechst Ag	Modifizierte Gallensäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
US5583239A (en) *	1995-05-30	1996-12-10	Lehigh University	Antimicrobial sterol conjugates
US5792635A (en) *	1995-06-07	1998-08-11	Magainin Pharmaceuticals, Inc.	Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
US5840936A (en) *	1995-06-07	1998-11-24	Magainin Pharmaceuticals Inc.	Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE)
US5795885A (en) *	1995-06-07	1998-08-18	Magainin Pharmaceuticals Inc.	Method of inhibiting profileration of cells by administering an aminosterol compound
US5874597A (en) *	1995-06-07	1999-02-23	Magainin Pharmaceuticals, Inc.	Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5763430A (en) *	1995-06-07	1998-06-09	Magainin Pharmaceuticals Inc.	Method of treating a viral infection by administering a steroid compound
US5847172A (en) *	1995-06-07	1998-12-08	Magainin Pharmaceuticals Inc.	Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5994336A (en) *	1995-06-07	1999-11-30	Magainin Pharmaceuticals Inc.	Method of inhibiting proliferation of cells by administering an aminosterol compound
US6143738A (en) *	1995-06-07	2000-11-07	Magainin Pharmaceuticals, Inc.	Therapeutic uses for an aminosterol compound
US7002027B1 (en)	1996-01-08	2006-02-21	Canji, Inc.	Compositions and methods for therapeutic use
US5789244A (en) *	1996-01-08	1998-08-04	Canji, Inc.	Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems
US20040014709A1 (en) *	1996-01-08	2004-01-22	Canji, Inc.	Methods and compositions for interferon therapy
US6392069B2 (en) *	1996-01-08	2002-05-21	Canji, Inc.	Compositions for enhancing delivery of nucleic acids to cells
FR2743561B1 (fr) *	1996-01-15	1998-02-20	Fournier Sca Lab	Derives de steroides, procede de preparation et utilisation en therapeutique
PT910382E (pt) *	1996-04-26	2003-10-31	Genaera Corp	Esqualamina em combinacao com outros agentes anti-cancro para o tratamento de tumores
US6596712B2 (en)	1996-04-26	2003-07-22	Genaera Corporation	Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
DE19633268A1 (de) *	1996-08-19	1998-02-26	Hoechst Ag	Polymere Gallensäure-Resorptionsinhibitoren mit gleichzeitiger Gallensäure-Adsorberwirkung
US6262283B1 (en)	1996-12-06	2001-07-17	Magainin Pharmaceuticals Inc.	Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
ATE268758T1 (de) *	1997-04-04	2004-06-15	Aventis Pharma Gmbh	Hypolipidämische propanolaminderivate
DE19845403B4 (de)	1998-10-02	2005-02-10	Aventis Pharma Deutschland Gmbh	Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE19950686B4 (de) *	1999-10-21	2006-06-29	Martin-Luther-Universität Halle-Wittenberg	Multifunktionelle Spacer
JP2004506599A (ja) *	1999-12-09	2004-03-04	ジェネーラ・コーポレーション	喘息および関連疾患を含むアトピー性アレルギーを処置するための標的としての喘息関連因子
EP1274718B1 (en) *	2000-04-12	2006-10-18	Genaera Corporation	A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group
US8975246B2 (en)	2001-04-17	2015-03-10	Galmed Research And Development Ltd.	Bile acid or bile salt fatty acid conjugates
PT1456377T (pt) *	2001-12-20	2019-09-10	Merck Sharp & Dohme	Composições de syn3 e processos
US7141559B2 (en)	2002-06-19	2006-11-28	Karo Bio Ab	Glucocorticoid receptor ligands for the treatment of metabolic disorders
PT1551860E (pt) *	2002-06-19	2007-02-28	Karobio Ab	Ligandos de receptores glucocorticóides para o tratamento de distúrbios metabólicos
GB0307918D0 (en)	2003-04-05	2003-05-14	Astrazeneca Ab	Therapeutic use
NZ543970A (en)	2003-06-04	2008-09-26	Canji Inc	Methods and compositions for interferon therapy
US7235678B2 (en) *	2004-03-30	2007-06-26	Council Of Scientific And Industrial Research	Bile acid derived steroidal dimers with novel amphiphilic topology having antifungal activity
US20050225942A1 (en) *	2004-04-07	2005-10-13	First International Computer Inc.	Plug-in cooling device
ES2318922B1 (es) *	2005-05-30	2010-02-12	Universidade De Santiago De Compostela	Nuevos dimeros derivados de acidos biliares funcionalizados en la posicion 3 del anillo a. metodo para la sintesis y aplicaciones.
ES2318927B1 (es) *	2005-08-25	2010-02-12	Universidade De Santiago De Compostela	Nuevos dimeros de acidos biliares funcionalizados en la posicion 24 de la cadena alquilica de la sal biliar. procedimientos para su obtencion y aplicaciones.
US7960439B1 (en)	2006-06-12	2011-06-14	Iowa State University Research Foundation, Inc.	Environmentally sensitive foldable oligomers
US7962543B2 (en) *	2007-06-01	2011-06-14	Advanced Micro Devices, Inc.	Division with rectangular multiplier supporting multiple precisions and operand types
KR101289199B1 (ko)	2008-08-28	2013-07-29	한양대학교 산학협력단	수용성기를 포함한 바일산 유도체 및 그의 응용
US20120301457A1 (en) *	2010-01-22	2012-11-29	Surachai Supattapone	LIPID COFACTORS FOR FACILITATING PROPOGATION OF PRPsc
EP4137137A1 (en)	2010-05-26	2023-02-22	Satiogen Pharmaceuticals, Inc.	Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
MX366925B (es)	2010-11-04	2019-07-31	Albireo Ab	Inhibidores de ibat para el tratamiento de enfermedades hepaticas.
US20130236541A1 (en)	2010-11-08	2013-09-12	Albireo Ab	Pharmaceutical combination comprising an ibat inhibitor and a bile acid binder
EA038594B1 (ru)	2011-10-28	2021-09-21	Шайр Хьюман Дженетик Терапис, Инк.	Ингибиторы рециркуляции желчных кислот для лечения гиперхолемии и холестатического заболевания печени
JP6217938B2 (ja)	2011-10-28	2017-10-25	ルメナファーマシューティカルズエルエルシー	小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤
KR20160002773A (ko)	2013-03-15	2016-01-08	루메나 파마수티컬즈, 인코포레이티드	원발성 담관염 및 염증성 장 질환 치료용 담즙산 재순환 억제제
AU2014229050A1 (en)	2013-03-15	2015-10-22	Lumena Pharmaceuticals Llc	Bile acid recycling inhibitors for treatment of Barrett's esophagus and gastroesophageal reflux disease
JO3301B1 (ar)	2013-04-26	2018-09-16	Albireo Ab	تعديلات بلورية على إيلوبيكسيبات
CA2952406A1 (en)	2014-06-25	2015-12-30	Ea Pharma Co., Ltd.	Solid formulation and method for preventing or reducing coloration thereof
EP3012252A1 (en)	2014-10-24	2016-04-27	Ferring BV	Crystal modifications of elobixibat
JP6954927B2 (ja)	2016-02-09	2021-10-27	アルビレオ・アクチボラグ	経口コレスチラミン製剤及びその使用
CA3011595C (en)	2016-02-09	2024-01-02	Albireo Ab	Cholestyramine pellets and methods for preparation thereof
CN108601744B (zh)	2016-02-09	2022-01-04	阿尔比里奥公司	口服考来烯胺制剂及其用途
CN111032019B (zh)	2017-08-09	2022-07-05	阿尔比里奥公司	考来烯胺颗粒、口服考来烯胺制剂及其用途
JP7328207B2 (ja)	2017-08-09	2023-08-16	アルビレオ・アクチボラグ	コレスチラミンペレット、経口コレスチラミン製剤、及びそれらの使用
EP3740494A4 (en)	2018-02-02	2021-11-03	Ripple Therapeutics Corporation	GLASS FORMULATIONS WITH STEROID DIMERS AND USES THEREOF
JP7391048B2 (ja)	2018-06-05	2023-12-04	アルビレオ・アクチボラグ	ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
US11801226B2 (en)	2018-06-20	2023-10-31	Albireo Ab	Pharmaceutical formulation of odevixibat
KR20210024033A (ko)	2018-06-20	2021-03-04	알비레오 에이비	오데빅시바트의 약학 제제
US11007142B2 (en)	2018-08-09	2021-05-18	Albireo Ab	Oral cholestyramine formulation and use thereof
US11549878B2 (en)	2018-08-09	2023-01-10	Albireo Ab	In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10722457B2 (en)	2018-08-09	2020-07-28	Albireo Ab	Oral cholestyramine formulation and use thereof
WO2020154815A1 (en)	2019-02-01	2020-08-06	Ripple Therapeutics Corporation	Crystalline forms of dexamethasone dimers and uses thereof
CN113453753B (zh)	2019-02-06	2024-07-23	阿尔比里奥公司	苯并硫氮杂环庚三烯化合物及其用作胆汁酸调节剂的用途
SG11202108566VA (en)	2019-02-06	2021-09-29	Albireo Ab	Benzothiadiazepine compounds and their use as bile acid modulators
EP4424363B1 (en)	2019-02-12	2026-04-29	Mirum Pharmaceuticals, Inc.	Methods for increasing growth in pediatric subjects having cholestatic liver disease
US12509469B2 (en)	2019-08-07	2025-12-30	Ripple Therapeutics Corporation	Compositions and methods for the treatment of pain and dependence disorders
CN116925168A (zh) *	2019-08-23	2023-10-24	深圳云合医药科技合伙企业(有限合伙)	胆汁酸衍生物及其组合物和应用
JP7665621B2 (ja)	2019-12-04	2025-04-21	アルビレオ・アクチボラグ	ベンゾチアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
CA3158195A1 (en)	2019-12-04	2021-06-10	Per-Goran Gillberg	Benzothia(di)azepine compounds and their use as bile acid modulators
CA3158181A1 (en)	2019-12-04	2021-06-10	Albireo Ab	Benzothia(di)azepine compounds and their use as bile acid modulators
WO2021110885A1 (en)	2019-12-04	2021-06-10	Albireo Ab	Benzothiadiazepine compounds and their use as bile acid modulators
CN114786772B (zh)	2019-12-04	2024-04-09	阿尔比里奥公司	苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
CA3176134A1 (en)	2020-05-01	2021-11-04	Ripple Therapeutics Corporation	Heterodimer compositions and methods for the treatment of ocular disorders
ES3002777T3 (en)	2020-08-03	2025-03-07	Albireo Ab	Benzothia(di)azepine compounds and their use as bile acid modulators
AU2021379076A1 (en)	2020-11-12	2023-06-08	Albireo Ab	Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
BR112023010799A2 (pt)	2020-12-04	2023-10-03	Albireo Ab	Compostos de benzotia(di)azepina e seus usos como moduladores de ácidos biliares
CN117412955A (zh)	2021-06-03	2024-01-16	阿尔比里奥公司	苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
WO2023216423A1 (zh) *	2022-05-13	2023-11-16	苏州慧疗生物医药科技有限公司	脂质化合物及其组合物，制备和用途
EP4536232A1 (en)	2022-06-09	2025-04-16	Albireo AB	Treating hepatitis
CN119487013A (zh)	2022-07-05	2025-02-18	阿尔比里奥公司	苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
EP4629997A1 (en)	2022-12-09	2025-10-15	Albireo AB	Asbt inhibitors in the treatment of renal diseases
WO2025146508A1 (en)	2024-01-05	2025-07-10	Albireo Ab	Benzothia(di)azepine compounds and their use as bile acid modulators
WO2025146507A1 (en)	2024-01-05	2025-07-10	Albireo Ab	Benzothia(di)azepine compounds and their use as bile acid modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4418059A (en) *	1981-07-20	1983-11-29	Montefiore Medical Center	Nucleoside ester compositions
IT1210874B (it) *	1982-04-15	1989-09-29	Istituto Chemioterapico	Sale di magnesio dell'acido chenodesossicolico e dell'acido ursodesossicolico, processo per lasua preparazione e composizioni terapeutiche che lo contengono come principio attivo.
EP0202703B1 (en) *	1985-05-15	1989-08-09	N.V. Gantax Pharmaceutica	Pharmaceutical compositions of the prodrug type, a process for the preparation thereof, a process for the preparation of them as prodrug functioning compounds and compounds obtained therein
DE3742798C2 (de) *	1987-12-17	1997-02-13	Freedom Chemical Co	Verfahren zur Herstellung des Magnesium-Doppelsalzes der Chenodesoxycholsäure und Ursodesoxycholsäure

1991
- 1991-12-04 US US07/802,413 patent/US5250524A/en not_active Expired - Lifetime
- 1991-12-04 DE DE59108326T patent/DE59108326D1/de not_active Expired - Lifetime
- 1991-12-04 FI FI915719A patent/FI106800B/fi active
- 1991-12-04 EP EP91120841A patent/EP0489423B1/de not_active Expired - Lifetime
- 1991-12-04 NZ NZ240846A patent/NZ240846A/en unknown
- 1991-12-04 IL IL10024091A patent/IL100240A/en not_active IP Right Cessation
- 1991-12-04 DK DK91120841.1T patent/DK0489423T3/da active
- 1991-12-04 ES ES91120841T patent/ES2096614T3/es not_active Expired - Lifetime
- 1991-12-04 AT AT91120841T patent/ATE144988T1/de not_active IP Right Cessation
- 1991-12-05 IE IE423591A patent/IE914235A1/en not_active Application Discontinuation
- 1991-12-05 CZ CS913697A patent/CZ281075B6/cs not_active IP Right Cessation
- 1991-12-05 NO NO914792A patent/NO304187B1/no not_active IP Right Cessation
- 1991-12-05 AU AU88849/91A patent/AU649089B2/en not_active Ceased
- 1991-12-05 CA CA002057099A patent/CA2057099C/en not_active Expired - Lifetime
- 1991-12-05 JP JP34837791A patent/JP3237882B2/ja not_active Expired - Lifetime
- 1991-12-05 ZA ZA919605A patent/ZA919605B/xx unknown
- 1991-12-05 HU HU913817A patent/HU213402B/hu not_active IP Right Cessation
- 1991-12-06 SI SI9111899A patent/SI9111899B/sl unknown
- 1991-12-06 YU YU189991A patent/YU48636B/sh unknown
- 1991-12-06 KR KR1019910022269A patent/KR100221690B1/ko not_active Expired - Fee Related
- 1991-12-06 PT PT99713A patent/PT99713B/pt active IP Right Grant
1994
- 1994-10-25 HR HR940751A patent/HRP940751B1/xx not_active IP Right Cessation
1995
- 1995-06-29 HU HU95P/P00553P patent/HU211900A9/hu unknown
1996
- 1996-11-07 GR GR960402941T patent/GR3021572T3/el unknown

Also Published As

Publication number	Publication date
US5250524A (en)	1993-10-05
NO304187B1 (no)	1998-11-09
AU649089B2 (en)	1994-05-12
IL100240A0 (en)	1992-09-06
DE59108326D1 (de)	1996-12-12
NO914792D0 (no)	1991-12-05
FI915719A0 (fi)	1991-12-04
HRP940751A2 (en)	1997-04-30
HRP940751B1 (en)	2000-12-31
CS369791A3 (en)	1992-06-17
AU8884991A (en)	1992-06-11
YU48636B (sh)	1999-03-04
IE914235A1 (en)	1992-06-17
IL100240A (en)	1995-10-31
ATE144988T1 (de)	1996-11-15
HUT62599A (en)	1993-05-28
ES2096614T3 (es)	1997-03-16
ZA919605B (en)	1992-08-26
KR920012108A (ko)	1992-07-25
HU213402B (en)	1997-06-30
EP0489423B1 (de)	1996-11-06
GR3021572T3 (en)	1997-02-28
PT99713B (pt)	1999-05-31
CA2057099C (en)	2005-05-17
FI106800B (fi)	2001-04-12
JP3237882B2 (ja)	2001-12-10
EP0489423A1 (de)	1992-06-10
CA2057099A1 (en)	1992-06-07
SI9111899B (sl)	2000-06-30
HU211900A9 (en)	1996-01-29
NZ240846A (en)	1994-04-27
PT99713A (pt)	1992-10-30
CZ281075B6 (cs)	1996-06-12
FI915719L (fi)	1992-06-07
KR100221690B1 (ko)	1999-10-01
NO914792L (no)	1992-06-09
SI9111899A (sl)	1998-04-30
HU913817D0 (en)	1992-02-28
JPH05294988A (ja)	1993-11-09
YU189991A (sh)	1995-10-03

Publication	Publication Date	Title
NO914792D0 (no)	1991-12-05	Gallesyrederivater, deres fremstilling og anvendelse som legemiddel
DK0624596T3 (da)	1998-10-07	Tetrazolderivater af galdesyrer, fremgangsmåde tilderes fremstilling og anvendelse af disse forbindelser som lægemidler
NO923944L (no)	1992-12-18	Derivater og analoger av 2-deoksy-2,3-didehydro-n-acetyl-neuraminsyre og anvendelse av disse som virusmotvirkende midler
NO883073L (no)	1989-01-11	3-desmetyl-mevalonsyrederivater, fremgangsmaate for fremstilling av dem, farmasoeytiske preparater paa basis av disse forbindelsene, deres anvendelse saavel som mellomprodukter.
LU90192I2 (fr)	1998-03-02	Desirudine et ses sels et dérivés pharmaceutiquement acceptables (revasc)
NO302474B1 (no)	1998-03-09	Sakarinderivater, farmasöytisk sammensetning og anvendelse derav
PT93246A (pt)	1990-08-31	Processo para a preparacao de compostos pirrolicos substituidos e de composicoes farmaceuticas que os contem
DK162883D0 (da)	1983-04-13	N-glucosylerede carboxylsyreamidderivater, fremgangsmade til fremstilling heraf samt deres anvendelse til pavirkning af organismens egen forsvarsmekanisme
DK346783D0 (da)	1983-07-28	Triphenylimidazolyloxyalkansyrer og derivater deraf, fremgangsmade til fremstilling deraf og farmaceutiske praeparater indeholdende disse forbindelser
ES2110414T3 (es)	1998-02-16	Derivados de sacarina utiles como inhibidores de enzimas proteoliticas y su preparacion.
DK0517986T3 (da)	1998-03-30	Transformerede erythrocytter, fremgangsmåde til fremstilling af samme og deres anvendelse i farmaceutiske præparater
DK199789D0 (da)	1989-04-25	Anvendelse af et phenylquinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et topisk farmaceutisk praeparat til behandling af hud- og/eller slimepithelsygdomme
DK162439C (da)	1992-03-23	Imidazol-2-ylthioalkansyrer og derivater deraf, fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK482185A (da)	1986-04-23	Peptider, deres fremstilling og anvendelse som laegemidler
DK383388D0 (da)	1988-07-08	3-demethyl-4-fluor-mevalonsyrederivater, deres fremstilling, farmaceutiske praeparater deraf, deres anvendelse og mellemprodukter til deres fremstilling
ES2124861T3 (es)	1999-02-16	Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
DK0411268T3 (da)	1995-08-14	Dibenzo(1,5)dioxocin-5-on-derivater, deres anvendelse i lægemidler og fremgangsmåde til deres fremstilling
FR2721929B1 (fr)	1996-12-20	Analogues stables, non hydrolysables, de diphosphates et leurs procedes de preparation
DE69201873D1 (de)	1995-05-11	Verfahren zur Herstellung optisch aktiver Dihydropyranderivate.
AR013096A1 (es)	2000-12-13	Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma.
DK163432C (da)	1992-07-20	Analogifremgangsmaade til fremstilling af oe1,2,4aatriazolo-oe4,3-aaaquinoxalin-4-amin-derivater eller farmaceutisk acceptable syreadditionssalte deraf
IT8814505V0 (it)	1988-11-30	Sistema di prova rapida per occhiali da sole presso i rivenditori